Results 201 to 210 of about 11,341 (256)

Advancing PROTAC Discovery Through Artificial Intelligence: Opportunities, Challenges, and Future Directions. [PDF]

Pharmaceuticals (Basel)
Park KS, Jeon M.
europepmc   +1 more source

A selective RPL15 PROTAC degrader enhances anti-PD-1 immunotherapy in a murine melanoma tumor model. [PDF]

Oncogene
Takahashi R, Yamamoto K, Toya H, Shoji H, Kawanishi K, Momosaki K, Yabe M, Takashima K, Muromoto R, Ichikawa S, Matsuda T, Kitai Y.   +11 more
europepmc   +1 more source

Correction to "DNA-Programmable Protein Degradation: Dynamic Control of Proteolysis-Targeting Chimera Activity via DNA Hybridization and Strand Displacement". [PDF]

JACS Au
Kashyap D, Haider S, Milne TA, Booth MJ.
europepmc   +1 more source

Hide and seek: targeting nuclear receptor PXR with inhibitors and PROTACs to improve drug efficacy and safety. [PDF]

Expert Opin Ther Targets
Huber AD, Chen T.
europepmc   +1 more source

Geochemical Modelling of Repository Systems: Limitations of the Thermodynamic Approach [PDF]

, 2017
Berner, Urs
core  

Control of airway basal stem cell-mediated lung repair by TGF-β signaling. [PDF]

Sci Adv
Zou T, Zhang S, Liu M, Chen Q, Wang S, Niu L, Chen YG, Zhang T, Zuo W.   +8 more
europepmc   +1 more source

Dual Aptamers-Based SETDB1 PROTACs as Effective Anti-Tumor Strategies for Breast Cancer. [PDF]

Adv Sci (Weinh)
Guo Y, Lv Y, Huang S, Liu C, Ouyang Y, Lan B, Xuan C.   +6 more
europepmc   +1 more source

Therapeutic horizons in the development of PROTAC-based EZH2 inhibitors: recent achievements, comparative analysis, and future perspectives. [PDF]

RSC Adv
S Abulkhair H.
europepmc   +1 more source

Unhooking the Hook: Optimization of the Aurora A Targeting PROTAC <b>JB170</b> to <b>CCT400028</b>, an <i>In Vitro</i> Degrader Chemical Probe. [PDF]

J Med Chem
O'Hanlon JA, Gutsche K, Müller JE, Ranjan Prusty N, Mirza A, Roumeliotis TI, Yang H, Stubbs M, Hallett ST, Eing L, McAndrew PC, Choudhary JS, Le Bihan YV, Caldwell J, van Montfort RLM, Workman P, Wolf E, Newton GK, Evans LE.   +18 more
europepmc   +1 more source

Therapeutic advances in acute myeloid leukemia: from LSD1 blockade to PROTAC-based strategies. [PDF]

Ann Med Surg (Lond)
Khan SA, Qamar MA, Feroze MT.
europepmc   +1 more source